 |
Senior Global Compound Market Access Leader, CVM&PH - Raritan New Jersey
Company: Disability Solutions
Location: Raritan, New Jersey
Posted On: 04/21/2024
Company Description At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/. Job Description Janssen Global Commercial Strategy Organization, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for a Global Compound Market Access Leader. This position will be based in Raritan, NJ. The Senior Compound Market Access Leader (SCMAL) is a career pathway and talent advancement opportunity to lead the strategic planning and implementation of the payer value generation and access strategies for innovative medicines in early development to commercialization. The position resides in the Cardiovascular, Metabolic and Pulmonary Hypertension (CVM&PH) area of the Global Commercial Strategy Organization and reports to VP of Market Access for CVM&PH. For the assigned therapeutic area, the SCMAL serves as the leading resource on access strategies and is an active member of the global clinical and commercial product teams, as well as the disease area strategy groups. They will be responsible for integrating pricing, market research, and epidemiology information to develop the optimal value strategy. The SCMAL will be responsible for the following activities in their disease area: Market Access Strategy: - Leads the Compound Market Access Team (CMAT) across parallel indications, which includes the core functions within Global Market Access (i.e., Health Economics, Patient Reported Outcomes [PRO], Access Policy, Pricing, Real-World Evidence & Analytics) to deliver the global market access strategy & key value communication tools for the brand.
- Design, develop and implements an integrated approach to all aspects of the payer value proposition from early development through and beyond loss of exclusivity for a complex portfolio of compounds and indications.
- Responsible for the strategic planning and implementation of the payer value generation and access strategies.
- Serve as the leading resource on access strategies and is an active member of the global clinical and commercial product teams, as well as the disease area strategy groups.
- Responsible for integrating pricing, payer research, health economic and epidemiology information to develop the optimal value strategy.
- Interact with Regional Market Access/Health Economics / Outcomes Research and Medical Affairs teams to coordinate and develop real world evidence generation in support of their access programs.
- Develop an integrated access strategy that reflects macro (health care reform, quality metrics, technology assessment) and disease specific (clinical profile, market segmentation, disease staging and clinical pathway) factors as well as the complexity of a companion diagnostic.
- Be responsible for ensuring that clinical development programs fully capture the value of innovative products to payers, physicians and patients. This includes strategic advice to teams on patient populations, trial design, selection of relevant endpoints as well as ensuring quality implementation of study protocols, case report forms, monitoring protocols, statistical analyses plans, etc.
- Drive the design and management of health outcomes studies including: systematic literature reviews, Real World Evidence studies, and user-friendly cost effectiveness and budget impact models.
- Be responsible for educating the commercial and R&D teams on key access trends and opportunities to shape their evolution.
- Provide leadership to the Clinical Development Team (CDT) in terms of market access data needs related to the clinical development plan; represent the access needs of the regions as a subject matter expert and advocate for the data necessary for positive reimbursement across the global markets.
- Take budgetary responsibility for defining and managing the market access discretionary budgets, ensuring that spending is managed effectively throughout the year and to plan.
- Develop deep expertise of the clinical and market access drivers unique to cell-based therapies and work to drive the debate externally to influence market access and reimbursement approaches to these novel therapies.
- Keep up to date with scientific developments, bringing the latest techniques and analyses to build the strongest possible value proposition.
- Understand the patient perspective of the disease and recommend strategies that can support the patient voice in key payer negotiations. Team Leadership:
|
 |
RSS Job Feeds